本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prelude Therapeutics Inc

0.7400
+0.05608.19%
盘后0.74000.00000.00%16:55 EST
成交量:11.08万
成交额:7.80万
市值:4,072.60万
市盈率:-0.42
高:0.7500
开:0.6840
低:0.6700
收:0.6840
数据加载中...

公司资料

公司名字:
Prelude Therapeutics Inc
交易所:
NASDAQ
成立时间:
2016
员工人数:
128
公司地址:
175 Innovation Boulevard,Wilmington,Delaware,United States
邮编:
19805
电话:
传真:
- -
简介:
Prelude Therapeutics Incorporated于2016年2月5日在特拉华州成立,是一家临床阶段的精密肿瘤学公司,致力于发现和开发针对高度未满足需求的癌症的关键驱动机制进行优化的小分子疗法。

董事

名称
职位
Kris Vaddi
Chief Executive Officer and Director
Paul A. Friedman
Chairman of the Board, Director
David Bonita
Director
Kelvin Neu
Director
Mardi C. Dier
Director
Victor Sandor
Director

股东

名称
职位
Kris Vaddi
Chief Executive Officer and Director
Brian Piper
Chief Financial Officer
Andrew P. Combs
Executive Vice President and Head of Chemistry
Christopher Pierce
Executive Vice President and Chief of Business Operations
David Mauro
Chief Medical Officer
Deborah Morosini
Executive Vice President and Chief of Clinical Affairs
Peggy A. Scherle
Chief Scientific Officer